Published in Transplantation on March 27, 2009
The predictive value of kidney allograft baseline biopsies for long-term graft survival. J Am Soc Nephrol (2013) 0.89
Kidney transplant survival in pediatric and young adults. BMC Nephrol (2011) 0.88
Steroids in kidney transplant patients. Semin Immunopathol (2011) 0.80
Comparative pharmacokinetic study of two mycophenolate mofetil formulations in stable kidney transplant recipients. Transpl Int (2012) 0.77
Comparison of azathioprine with mycophenolate mofetil in a living donor kidney transplant programme. Indian J Nephrol (2011) 0.76
Polyomavirus Reactivation and Immune Responses to Kidney-Specific Self-Antigens in Transplantation. J Am Soc Nephrol (2016) 0.76
CRTC2 polymorphism as a risk factor for the incidence of metabolic syndrome in patients with solid organ transplantation. Pharmacogenomics J (2015) 0.76
Cyclosporine versus tacrolimus: cost-effectiveness analysis for renal transplantation in Brazil. Rev Saude Publica (2015) 0.75
Induction Therapy for Kidney Transplant Recipients: Do We Still Need Anti-IL2 Receptor Monoclonal Antibodies? Am J Transplant (2016) 0.75
Heterogeneity of induction therapy in Spain: changing patterns according to year, centre, indications and results. NDT Plus (2010) 0.75
Antibodies against MICA antigens and kidney-transplant rejection. N Engl J Med (2007) 5.31
Lymphomas after solid organ transplantation: a collaborative transplant study report. Am J Transplant (2004) 3.25
Multicenter analysis of kidney preservation. Transplantation (2007) 2.39
C3 polymorphisms and allograft outcome in renal transplantation. N Engl J Med (2009) 2.29
Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies. Lancet (2005) 2.02
Cardiovascular death in kidney recipients treated with renin-angiotensin system blockers. Transplantation (2014) 1.96
H-Y as a minor histocompatibility antigen in kidney transplantation: a retrospective cohort study. Lancet (2008) 1.85
Long-term prospective study of steroid withdrawal in kidney and heart transplant recipients. Am J Transplant (2005) 1.78
The effect of donor gender on graft survival. J Am Soc Nephrol (2002) 1.72
No association of kidney graft loss with human leukocyte antigen antibodies detected exclusively by sensitive Luminex single-antigen testing: a Collaborative Transplant Study report. Transplantation (2011) 1.67
Pediatric kidney transplantation: analysis of donor age, HLA match, and posttransplant non-Hodgkin lymphoma: a collaborative transplant study report. Transplantation (2010) 1.60
Effect of cytomegalovirus prophylaxis with immunoglobulin or with antiviral drugs on post-transplant non-Hodgkin lymphoma: a multicentre retrospective analysis. Lancet Oncol (2007) 1.51
Prolongation of long-term kidney graft survival by a simultaneous liver transplant: the liver does it, and the heart does it too. Transplantation (2002) 1.48
Impact of HLA compatibility on lung transplant survival and evidence for an HLA restriction phenomenon: a collaborative transplant study report. Transplantation (2010) 1.42
Kidney graft survival in Europe and the United States: strikingly different long-term outcomes. Transplantation (2013) 1.36
Improved long-term outcomes after renal transplantation associated with blood pressure control. Am J Transplant (2005) 1.18
Disassociation between risk of graft loss and risk of non-Hodgkin lymphoma with induction agents in renal transplant recipients. Transplantation (2006) 1.11
Three-year outcomes following 1420 ABO-incompatible living-donor kidney transplants performed after ABO antibody reduction: results from 101 centers. Transplantation (2015) 1.05
No improvement of patient or graft survival in transplant recipients treated with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers: a collaborative transplant study report. J Am Soc Nephrol (2006) 1.05
Influence of time of rejection on long-term graft survival in renal transplantation. Transplantation (2008) 1.04
Effect of human leukocyte antigen compatibility on kidney graft survival: comparative analysis of two decades. Transplantation (2007) 1.03
Epidemiology of pretransplant EBV and CMV serostatus in relation to posttransplant non-Hodgkin lymphoma. Transplantation (2009) 1.02
Metabolic control improves long-term renal allograft and patient survival in type 1 diabetes. J Am Soc Nephrol (2008) 1.02
Cytomegalovirus prophylaxis and graft outcome in solid organ transplantation: a collaborative transplant study report. Am J Transplant (2004) 1.01
Effect on kidney graft survival of reducing or discontinuing maintenance immunosuppression after the first year posttransplant. Transplantation (2008) 1.00
Inosine monophosphate dehydrogenase polymorphisms and renal allograft outcome. Transplantation (2012) 0.99
Donor ABCB1 variant associates with increased risk for kidney allograft failure. J Am Soc Nephrol (2012) 0.98
Presensitized kidney graft recipients with HLA class I and II antibodies are at increased risk for graft failure: a Collaborative Transplant Study report. Hum Immunol (2009) 0.93
HLA antibodies and the occurrence of early adverse events in the modern era of transplantation: a collaborative transplant study report. Transplantation (2009) 0.91
Impact of HLA mismatching on incidence of posttransplant non-hodgkin lymphoma after kidney transplantation. Transplantation (2010) 0.89
HLA matching and kidney transplantation: beyond graft survival. Clin Transpl (2013) 0.88
Genotypic diversity of complement component C4 does not predict kidney transplant outcome. J Am Soc Nephrol (2010) 0.86
Risks of allogeneic hand transplantation. Microsurgery (2004) 0.84
Increased pretransplantation plasma kynurenine levels do not protect from but predict acute kidney allograft rejection. Hum Immunol (2010) 0.83
Association of Kidney Graft Loss With De Novo Produced Donor-Specific and Non-Donor-Specific HLA Antibodies Detected by Single Antigen Testing. Transplantation (2015) 0.82
The collaborative transplant study registry. Transplant Rev (Orlando) (2013) 0.81
Identification of highly responsive kidney transplant recipients using pretransplant soluble CD30. J Am Soc Nephrol (2002) 0.81
Analysis of positive kidney, heart, and liver transplant crossmatches reported to the Collaborative Transplant Study. Hum Immunol (2009) 0.81
Transplantation of the type 1 diabetic patient: the long-term benefit of a functioning pancreas allograft. Clin J Am Soc Nephrol (2010) 0.81
VEGF 936 C/T gene polymorphism in renal transplant recipients: association of the T allele with good graft outcome. Hum Immunol (2007) 0.80
Soluble CD30 as a predictor of kidney graft outcome. Transplantation (2002) 0.79
Posttransplant sCD30 as a predictor of kidney graft outcome. Transplantation (2011) 0.79
Natural killer-cell receptor polymorphisms and posttransplantation non-Hodgkin lymphoma. Blood (2010) 0.79
Association of mismatches for HLA-DR with incidence of posttransplant hip fracture in kidney transplant recipients. Transplantation (2011) 0.78
Influence of Current and Previous Smoking on Cancer and Mortality After Kidney Transplantation. Transplantation (2016) 0.78
Reduced rate of cardiovascular death after cytomegalovirus prophylaxis in renal transplant recipients. Transplantation (2015) 0.77
Deleterious impact of mismatching for human leukocyte antigen-C in presensitized recipients of kidney transplants. Transplantation (2011) 0.77
Deleterious impact of HLA-DRB1 allele mismatch in sensitized recipients of kidney retransplants. Transplantation (2013) 0.77
The role of pretransplant dialysis modality on renal allograft outcome. Nephrol Dial Transplant (2011) 0.76
Does borderline kidney allograft rejection always require treatment? Transplantation (2010) 0.76
Response to A reassessment of the Survival Advantage of Simultaneous Kidney-Pancreas Versus Kidney-Alone Transplantation. Transplantation (2015) 0.75
Renin-Angiotensin system blockers and cardiovascular death in kidney recipients. Transplantation (2014) 0.75
Predictive power of ELISA-detected anti-HLA class I antibodies in pediatric kidney transplantation. Transplant Proc (2001) 0.75
Investigation of the relationship between maintenance dose of cyclosporine and nephrotoxicity or hypertension. Transplant Proc (2001) 0.75
Association of single nucleotide polymorphisms on chromosome 9p21.3 with cardiovascular death in kidney transplant recipients. Transplantation (2013) 0.75
Which human leukocyte antigen antibodies are really clinically relevant? Hum Immunol (2009) 0.75
HLA Matching in Pediatric Kidney Transplantation: HLA Poorly Matched Living Donor Transplants Versus HLA Well Matched Deceased Donor Transplants. Transplantation (2017) 0.75
Association of pretransplant soluble glycoprotein 130 (sgp130) plasma levels and posttransplant acute tubular necrosis in renal transplant recipients. Transplantation (2009) 0.75
Genetic polymorphisms of adhesion molecules and kidney transplant survival. Transplantation (2010) 0.75
Clinical outcome with low-dose valacyclovir in high-risk renal transplant recipients: a 10-year experience. Nephrol Dial Transplant (2012) 0.75
High Posttransplant Cancer Incidence in Renal Transplanted Patients With Pretransplant Cancer. Transplantation (2017) 0.75